Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Sorting out the roles of PPARα in energy metabolism and vascular homeostasis
Philippe Lefebvre, … , Jean-Charles Fruchart, Bart Staels
Philippe Lefebvre, … , Jean-Charles Fruchart, Bart Staels
Published March 1, 2006
Citation Information: J Clin Invest. 2006;116(3):571-580. https://doi.org/10.1172/JCI27989.
View: Text | PDF
Review Series Article has an altmetric score of 9

Sorting out the roles of PPARα in energy metabolism and vascular homeostasis

  • Text
  • PDF
Abstract

PPARα is a nuclear receptor that regulates liver and skeletal muscle lipid metabolism as well as glucose homeostasis. Acting as a molecular sensor of endogenous fatty acids (FAs) and their derivatives, this ligand-activated transcription factor regulates the expression of genes encoding enzymes and transport proteins controlling lipid homeostasis, thereby stimulating FA oxidation and improving lipoprotein metabolism. PPARα also exerts pleiotropic antiinflammatory and antiproliferative effects and prevents the proatherogenic effects of cholesterol accumulation in macrophages by stimulating cholesterol efflux. Cellular and animal models of PPARα help explain the clinical actions of fibrates, synthetic PPARα agonists used to treat dyslipidemia and reduce cardiovascular disease and its complications in patients with the metabolic syndrome. Although these preclinical studies cannot predict all of the effects of PPARα in humans, recent findings have revealed potential adverse effects of PPARα action, underlining the need for further study. This Review will focus on the mechanisms of action of PPARα in metabolic diseases and their associated vascular pathologies.

Authors

Philippe Lefebvre, Giulia Chinetti, Jean-Charles Fruchart, Bart Staels

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 Total
Citations: 13 29 26 25 24 23 17 15 21 19 18 32 21 21 16 21 19 15 9 4 388
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (388)

Title and authors Publication Year
Molecular mechanisms in liver repair and regeneration: from physiology to therapeutics
Ma X, Huang T, Chen X, Li Q, Liao M, Fu L, Huang J, Yuan K, Wang Z, Zeng Y
Signal Transduction and Targeted Therapy 2025
Future Directions in Diabetic Retinopathy Treatment: Stem Cell Therapy, Nanotechnology, and PPARα Modulation
Kąpa M, Koryciarz I, Kustosik N, Jurowski P, Pniakowska Z
Journal of Clinical Medicine 2025
Current Therapeutic Landscape for Metabolic Dysfunction-Associated Steatohepatitis
Devasia AG, Ramasamy A, Leo CH
International Journal of Molecular Sciences 2025
Aquaporin five deficiency suppresses fatty acid oxidation and delays liver regeneration through the transcription factor PPAR
Li B, Liu S, Han W, Song P, Sun H, Cao X, Di G, Chen P
The Journal of Biological Chemistry 2025
PPAR-γ in Melanoma and Immune Cells: Insights into Disease Pathogenesis and Therapeutic Implications
Sobolev V, Tchepourina E, Soboleva A, Denisova E, Korsunskaya I, Mezentsev A
Cells 2025
Competitive Ligand-Induced Recruitment of Coactivators to Specific PPARα/δ/γ Ligand-Binding Domains Revealed by Dual-Emission FRET and X-Ray Diffraction of Cocrystals
Kamata S, Honda A, Yashiro S, Kaneko C, Komori Y, Shimamura A, Masuda R, Oyama T, Ishii I
Antioxidants 2025
Impact of Selective Peroxisome Proliferator-Activated Receptor (PPAR)-α Modulators and Fibrates on Microvascular Disease: Is There Still Room?
Marinho LL, Ribeiro ML, Lawler PR, Iatan I, Godoy LC, Rached FH, Maranhão RC
Current atherosclerosis reports 2025
PPARα Genetic Deletion Reveals Global Transcriptional Changes in the Brain and Exacerbates Cerebral Infarction in a Mouse Model of Stroke
Hamblin MH, Boese AC, Murad R, Lee JP
International Journal of Molecular Sciences 2025
Gain-of-function PPM1D mutations attenuate ischemic stroke.
He W, Li Y, Fan J, Liu Y, Yuan M, Cheng S, Huang X, Yan B, Zhang Z, Xiu Y, Zhu H, Lan T, Chang Z, Jiang Y, Li H, Meng X, Wang Y, Van Kaer L, Verkhratsky A, Wang Y, Shi FD, Jin WN
Cell death and differentiation 2025
Selective PPARα Modulator (SPPARMα) in the Era of the MASLD Pandemic: Current Insights and Future Prospects
Sugihara T
Yonago Acta Medica 2025
Conjugated bile acids promote metabolic dysfunction-associated steatotic liver disease through inducing nuclear translocation of sphingosine-1-phosphate receptor 2 to disrupt peroxisome proliferator-activated receptor alpha
Miao RR, Tan MY, Shao HB, Sun ZM, Zhan S, Liang WS, Liu XH, Li KQ, Cheng YY, Wu XF, Xu R, Cui SX, Hai Y, Qu XJ
Cell Communication and Signaling : CCS 2025
Lipid exposure leads to metabolic dysfunction in fetal sheep cardiomyocytes
Chattergoon NN, Bose K, Louey S, Jonker SS
Physiological Reports 2025
Genome-wide association study for feed efficiency indicator traits in Nellore cattle considering genotype-by-environment interactions
Silva Neto JB, Brito LF, Mota LF, Magnabosco CU, Baldi F
Frontiers in Genetics 2025
The Role of Nuclear Receptors in the Pathogenesis and Treatment of Non-alcoholic Fatty Liver Disease
Yang Z, Danzeng A, Liu Q, Zeng C, Xu L, Mo J, Pingcuo C, Wang X, Wang C, Zhang B, Zhang B
International journal of biological sciences 2024
Metabolic remodeling in cardiac hypertrophy and heart failure with reduced ejection fraction occurs independent of transcription factor EB in mice
Dörmann N, Hammer E, Struckmann K, Rüdebusch J, Bartels K, Wenzel K, Schulz J, Gross S, Schwanz S, Martin E, Fielitz B, Pablo Tortola C, Hahn A, Benkner A, Völker U, Felix SB, Fielitz J
Frontiers in Cardiovascular Medicine 2024
C-X-C chemokine receptor type 4 promotes tubular cell senescence and renal fibrosis through β-catenin-inhibited fatty acid oxidation.
Wu Q, Chen Q, Xu D, Wang X, Ye H, Li X, Xiong Y, Li J, Zhou S, Miao J, Shen W, Liu Y, Niu H, Tang Y, Zhou L
Journal of Cellular and Molecular Medicine 2024
Impact of pemafibrate on lipid profile and insulin resistance in hypertriglyceridemic patients with coronary artery disease and metabolic syndrome.
Nakamura A, Kagaya Y, Saito H, Kanazawa M, Sato K, Miura M, Kondo M, Endo H
Heart and Vessels 2024
Circadian Rhythm Alteration of the Core Clock Genes and the Lipid Metabolism Genes Induced by High-Fat Diet (HFD) in the Liver Tissue of the Chinese Soft-Shelled Turtle (Trionyx sinensis)
Liu L, Liu L, Deng S, Zou L, He Y, Zhu X, Li H, Hu Y, Chu W, Wang X
Genes & development 2024
Futile lipid cycling: from biochemistry to physiology.
Sharma AK, Khandelwal R, Wolfrum C
Nature metabolism 2024
Gentiopicroside improves non-alcoholic steatohepatitis by activating PPARα and suppressing HIF1
Huang C, Yong Q, Lu Y, Wang L, Zheng Y, Zhao L, Li P, Peng C, Jia W, Liu F
Frontiers in pharmacology 2024
pparβ regulates lipid catabolism by mediating acox and cpt-1 genes in Scophthalmus maximus under heat stress.
Zhao T, Ma A, Huang Z, Liu Z, Sun Z, Zhu L, Chang H
Fish Physiology and Biochemistry 2024
Different Coactivator Recruitment to Human PPARα/δ/γ Ligand-Binding Domains by Eight PPAR Agonists to Treat Nonalcoholic Fatty Liver Disease
Kamata S, Honda A, Kashiwagi N, Shimamura A, Yashiro S, Komori Y, Hosoda A, Akahoshi N, Ishii I
Biomedicines 2024
Oleoylethanolamide and Palmitoylethanolamide Enhance IFNβ-Induced Apoptosis in Human Neuroblastoma SH-SY5Y Cells.
Camoglio C, Balla J, Fadda P, Dedoni S
Molecules (Basel, Switzerland) 2024
LINC317.5 as a novel biomarker for hypertriglyceridemia in normal glucose metabolism.
Yang Y, Sun M, Yan S, Yao N, Li X, Wu C, Wu Z, Wang F, Cui W, Li B
Cell Death Discovery 2024
Unlocking new avenues for neuropsychiatric disease therapy: the emerging potential of Peroxisome proliferator-activated receptors as promising therapeutic targets.
Dey AD, Mannan A, Dhiman S, Singh TG
Psychopharmacology 2024
Mitochondria Transplantation Promotes Corneal Epithelial Wound Healing
Raz D, Ben-Yaakov K, Levi M, Bertolin M, Ferrari S, Ponzin D, Busin M, Leiba H, Marcovich AL, Eisenberg-Lerner A, Rotfogel Z
Investigative ophthalmology & visual science 2024
m6A epitranscriptomic and epigenetic crosstalk in cardiac fibrosis
Liu ZY, Lin LC, Liu ZY, Yang JJ, Tao H
Molecular Therapy 2024
Role of liver sinusoidal endothelial cell in metabolic dysfunction-associated fatty liver disease
He Q, He W, Dong H, Guo Y, Yuan G, Shi X, Wang D, Lu F
Cell communication and signaling : CCS 2024
Peroxisome proliferator-activated receptors: Key regulators of tumor progression and growth
Asgharzadeh F, Memarzia A, Alikhani V, Beigoli S, Boskabady MH
Translational oncology 2024
PPARs in Clinical Experimental Medicine after 35 Years of Worldwide Scientific Investigations and Medical Experiments
Skoczyńska A, Ołdakowska M, Dobosz A, Adamiec R, Gritskevich S, Jonkisz A, Lebioda A, Adamiec-Mroczek J, Małodobra-Mazur M, Dobosz T
Biomolecules 2024
The Plasma Levels of Protein Adiponectin (AdipoQ) and Meteorin-Like (Metrnl) in Newly Diagnosed Type 2 Diabetes Mellitus.
Phuong LDT, Tran Huy T, Huynh Quang T
Diabetes, metabolic syndrome and obesity : targets and therapy 2024
Endoplasmic reticulum stress induces hepatic steatosis through interaction between PPARα and FoxO6 in vivo and in vitro.
Kim DH
Journal of molecular medicine (Berlin, Germany) 2024
Peroxisome proliferator-activated receptor agonists: A new hope towards the management of alcoholic liver disease
Durairajan SS, Singh AK, Iyaswamy A
World Journal of Gastroenterology 2024
Intermittent Fasting Regulates Metabolic Homeostasis and Improves Cardiovascular Health
Diab R, Dimachkie L, Zein O, Dakroub A, Eid AH
Cell Biochemistry and Biophysics 2024
Selective activation of PPARα by pemafibrate mitigates peritoneal inflammation and fibrosis through suppression of NLRP3 inflammasome and modulation of inflammation
Shinkai Y, Sasaki K, Tamura R, Ike T, Takahashi A, Osaki Y, Ishiuchi N, Maeoka Y, Nakashima A, Masaki T
Scientific Reports 2024
Topical hADSCs-HA Gel Promotes Skin Regeneration and Angiogenesis in Pressure Ulcers by Paracrine Activating PPARβ/δ Pathway
Jin C, Zhao R, Hu W, Wu X, Zhou L, Shan L, Wu H
Drug Design, Development and Therapy 2024
Metabolic Side Effects from Antipsychotic Treatment with Clozapine Linked to Aryl Hydrocarbon Receptor (AhR) Activation
Fehsel K
Biomedicines 2024
Novel intervention for alcohol-associated liver disease
Gao FQ, Zhu JQ, Feng XD
World Journal of Gastroenterology 2024
Elafibranor: A promising treatment for alcohol-associated liver disease?
Wei H, Sang LX, Chang B
World Journal of Gastroenterology 2024
Usefulness of pemafibrate for non-alcoholic fatty liver disease with hypertriglyceridemia
Kikuchi M, Kikuchi M, Konishi M
Clinical and Experimental Hepatology 2024
Gut Microbiota–Mediated hsa_circ_0126925 Targets BCAA Metabolic Enzyme BCAT2 to Exacerbate Colorectal Cancer Progression
Yao H, Xu J, Zhou A, Shen D, Dong Q, Yang X, Li M, Mi X, Lu Y, Zhong R, Shi X, Tai Q, Chen G, Shi B, Sun L, Zhou D, Yao Y, He S
Molecular Cancer Research 2024
Mitonuclear Communication in Stem Cell Function.
Peng B, Wang Y, Zhang H
Cell proliferation 2024
Understanding the contemporary high obesity rate from an evolutionary genetic perspective
Wu T, Xu S
Hereditas 2023
Molecular mechanism of Cuscutae semen–radix rehmanniae praeparata in relieving reproductive injury of male rats induced with tripterygium wilfordii multiglycosides: A tandem mass tag-based proteomics analysis
Han S, Dai Y, Sun L, Xing Y, Ding Y, Zhang X, Xu S
Frontiers in pharmacology 2023
Understanding the Potential Role of Nanotechnology in Liver Fibrosis: A Paradigm in Therapeutics
Singh S, Sharma N, Shukla S, Behl T, Gupta S, Anwer MK, Vargas-De-La-Cruz C, Bungau SG, Brisc C
Molecules (Basel, Switzerland) 2023
Targeting mTOR for Anti-Aging and Anti-Cancer Therapy
Fu W, Wu G
Molecules (Basel, Switzerland) 2023
Drugs against metabolic diseases as potential senotherapeutics for aging-related respiratory diseases
Matsubayashi S, Ito S, Araya J, Kuwano K
Frontiers in Endocrinology 2023
Adriamycin downregulates the expression of KLF4 in cardiomyocytes in vitro and contributes to impaired cardiac energy metabolism in Adriamycin-induced cardiomyopathy
Mohan UP, Pichiah PB, Arunachalam S
3 Biotech 2023
An insight to treat cardiovascular diseases through phytochemicals targeting PPAR-α.
Sharma S, Sharma D, Dhobi M, Wang D, Tewari D
Molecular and Cellular Biochemistry 2023
Osteocytes contribute via nuclear receptor PPAR-alpha to maintenance of bone and systemic energy metabolism
Chougule A, Baroi S, Czernik PJ, Crowe E, Chang MR, Griffin PR, Lecka-Czernik B
Frontiers in Endocrinology 2023
Novel Selective PPARα Modulator Pemafibrate for Dyslipidemia, Nonalcoholic Fatty Liver Disease (NAFLD), and Atherosclerosis.
Yamashita S, Rizzo M, Su TC, Masuda D
Metabolites 2023
The role of Huidouba in regulating skeletal muscle metabolic disorders in prediabetic mice through AMPK/PGC-1α/PPARα pathway.
Tian Y, Shi D, Liao H, Lu B, Pang Z
Diabetology & metabolic syndrome 2023
Peroxisome proliferator-activated receptors as targets to treat metabolic diseases: Focus on the adipose tissue, liver, and pancreas
Souza-Tavares H, Miranda CS, Vasques-Monteiro IM, Sandoval C, Santana-Oliveira DA, Silva-Veiga FM, Fernandes-da-Silva A, Souza-Mello V
World Journal of Gastroenterology 2023
Emerging roles of noncoding RNAs in human cancers.
Wu S, Wu Y, Deng S, Lei X, Yang X
Discover. Oncology 2023
Ectopic Lipid Accumulation Correlates with Cellular Stress in Rabbit Blastocysts from Diabetic Mothers
Schindler M, Geisler SM, Seeling T, Navarrete Santos A
International journal of molecular sciences 2023
Long Non-coding RNA Involved in the Pathophysiology of Atrial Fibrillation.
Zhong Z, Li X, Gao L, Wu X, Ye Y, Zhang X, Zeng Q, Zhou C, Lu X, Wei Y, Ding Y, Chen S, Zhou G, Xu J, Liu S
Cardiovascular Drugs and Therapy 2023
Screening of potential key ferroptosis-related genes in Chronic Obstructive Pulmonary Disease
Cao Y, Pan H, Yang Y, Zhou J, Zhang G
International journal of chronic obstructive pulmonary disease 2023
Circadian clock and lipid metabolism disorders: a potential therapeutic strategy for cancer
Liu M, Zhang Z, Chen Y, Feng T, Zhou Q, Tian X
Frontiers in Endocrinology 2023
Impact of chiglitazar on glycemic control in type 2 diabetic patients with metabolic syndrome and insulin resistance: A pooled data analysis from two phase III trials
Ning Z, Ai G, Chen B, Yao H, Cao H, Pan D, Lu X
Journal of Diabetes 2023
Two Argan Oil Phytosterols, Schottenol and Spinasterol, Attenuate Oxidative Stress and Restore LPS-Dysregulated Peroxisomal Functions in Acox1−/− and Wild-Type BV-2 Microglial Cells
Essadek S, Gondcaille C, Savary S, Samadi M, Vamecq J, Lizard G, El Kebbaj R, Latruffe N, Benani A, Nasser B, Cherkaoui-Malki M, Andreoletti P
Antioxidants 2023
Targeting the retinoic acid signaling pathway as a modern precision therapy against cancers
Lavudi K, Nuguri SM, Olverson Z, Dhanabalan AK, Patnaik S, Kokkanti RR
Frontiers in Cell and Developmental Biology 2023
Peroxisome Proliferator-Activated Receptor α and γ Gene Polymorphisms among South Indian Patients with Diabetic Dyslipidaemia
Bage IJ, Kamalanathan S, Selvarajan S, Sahoo J, Mathaiyan J, Naik D
Indian journal of endocrinology and metabolism 2023
Peroxisome proliferator-activated receptor-α (PPARα) regulates wound healing and mitochondrial metabolism in the cornea
Liang W, Huang L, Whelchel A, Yuan T, Ma X, Cheng R, Takahashi Y, Karamichos D, Ma JX
Proceedings of the National Academy of Sciences 2023
Analogues of Anticancer Natural Products: Chiral Aspects
Valentová J, Lintnerová L, Miklášová N, Oboňová B, Habala L
International journal of molecular sciences 2023
Metabolic reprogramming and lipid droplets are involved in Zika virus replication in neural cells
Dias SS, Cunha-Fernandes T, Souza-Moreira L, Soares VC, Lima GB, Azevedo-Quintanilha IG, Santos J, Pereira-Dutra F, Freitas C, Reis PA, Rehen SK, Bozza FA, Souza TM, de Almeida CJ, Bozza PT
Journal of Neuroinflammation 2023
Design and Synthesis of Novel Indole Ethylamine Derivatives as a Lipid Metabolism Regulator Targeting PPARα/CPT1 in AML12 Cells
Liu YC, Wei G, Liao ZQ, Wang FX, Zong C, Qiu J, Le Y, Yu ZL, Yang SY, Wang HS, Dou XB, Wang CY
Molecules (Basel, Switzerland) 2023
Evaluation of the effects of pemafibrate on metabolic dysfunction‐associated steatotic liver disease with hypertriglyceridemia using magnetic resonance elastography combined with fibrosis‐4 index and the magnetic resonance imaging‐aspartate aminotransferase score
Ichikawa T, Oba H, Owada M, Watanabe K, Yoshimura T, Fuchigami A, Nakamura A
2023
Neurotrophins and neural stem cells in posttraumatic brain injury repair
Guo W, Liu K, Wang Y, Ge X, Ma Y, Qin J, Zhang C, Zhao Y, Shi C
2023
Adipose triglyceride lipase mediated lipid catabolism is essential for bronchiolar regeneration
Manu Manjunath Kanti, Isabelle Striessnig-Bina, Beatrix I. Wieser, Silvia Schauer, Gerd Leitinger, Thomas O. Eichmann, Martina Schweiger, Margit Winkler, Elke Winter, Andrea Lana, Iris Kufferath, Leigh M. Marsh, Grazyna Kwapiszewska, Rudolf Zechner, Gerald Hoefler, Paul W Vesely
JCI Insight 2022
Peroxisome Proliferator–Activated Receptor-α: A Pivotal Regulator of the Gastrointestinal Tract
Y Guo, B Wang, H Gao, R Hua, L Gao, C He, Y Wang, J Xu
Frontiers in Molecular Biosciences 2022
Signaling pathways of chronic kidney diseases, implications for therapeutics
Q Yuan, B Tang, C Zhang
Signal Transduction and Targeted Therapy 2022
FGF9 Alleviates the Fatty Liver Phenotype by Regulating Hepatic Lipid Metabolism
Zhao F, Zhang L, Zhang M, Huang J, Zhang J, Chang Y
Frontiers in pharmacology 2022
Accumulation of Lipid Droplets in a Novel Bietti Crystalline Dystrophy Zebrafish Model With Impaired PPARα Pathway
Gao P, Jia D, Li P, Huang Y, Hu H, Sun K, Lv Y, Chen X, Han Y, Zhang Z, Ren X, Wang Q, Liu F, Tang Z, Liu M
Investigative ophthalmology & visual science 2022
The Structure Basis of Phytochemicals as Metabolic Signals for Combating Obesity
Li X, Zheng L, Zhang B, Deng ZY, Luo T
Frontiers in Nutrition 2022
Clinically Relevant Dose of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor α Modulator (SPPARMα), Lowers Serum Triglyceride Levels by Targeting Hepatic PPARα in Mice
Zhang Z, Diao P, Zhang X, Nakajima T, Kimura T, Tanaka N
Biomedicines 2022
Population-based meta-analysis and gene-set enrichment identifies FXR/RXR pathway as common to fatty liver disease and serum lipids.
Handelman SK, Puentes YM, Kuppa A, Chen Y, Du X, Feitosa MF, Palmer ND, Speliotes EK
Hepatology Communications 2022
The Intestinal Redox System and Its Significance in Chemotherapy-Induced Intestinal Mucositis.
Yu QQ, Zhang H, Guo Y, Han B, Jiang P
Oxidative medicine and cellular longevity 2022
Nanoparticle Delivery of Novel PDE4B Inhibitor for the Treatment of Alcoholic Liver Disease.
Ma J, Kumar V, Mahato RI
Pharmaceutics 2022
Fatty Acid Amide Hydrolase Deficiency Is Associated with Deleterious Cardiac Effects after Myocardial Ischemia and Reperfusion in Mice.
Rajlic S, Surmann L, Zimmermann P, Weisheit CK, Bindila L, Treede H, Velten M, Daiber A, Duerr GD
International journal of molecular sciences 2022
Short-Term Omega-3 Supplementation Modulates Novel Neurovascular and Fatty Acid Metabolic Proteome Changes in the Retina and Ophthalmic Artery of Mice with Targeted Cyp2c44 Gene Deletion
Perumal N, Herfurth A, Pfeiffer N, Manicam C
Cells 2022
Mechanistic insights into the peroxisome proliferator-activated receptor alpha as a transcriptional suppressor
Yagai T, Nakamura T
Frontiers in Medicine 2022
Pemafibrate improves liver dysfunction and non-invasive surrogates for liver fibrosis in patients with non-alcoholic fatty liver disease with hypertriglyceridemia: a multicenter study
Morishita A, Oura K, Takuma K, Nakahara M, Tadokoro T, Fujita K, Tani J, Shi T, Himoto T, Tatsuta M, Moriya A, Senoo T, Tsutsui A, Nagano T, Takaguchi K, Ono M, Masaki T
Hepatology International 2022
RUNX2 recruits the NuRD(MTA1)/CRL4B complex to promote breast cancer progression and bone metastasis
Yin X, Teng X, Ma T, Yang T, Zhang J, Huo M, Liu W, Yang Y, Yuan B, Yu H, Huang W, Wang Y
Cell Death and Differentiation 2022
Saroglitazar ameliorates monosodium glutamate-induced obesity and associated inflammation in Wistar rats: Plausible role of NLRP3 inflammasome and NF- κB
Nabi S, Bhandari U, Haque SE
Iranian Journal of Basic Medical Sciences 2022
Antidiabetic Effect of Rehmanniae Radix Based on Regulation of TRPV1 and SCD1
Liu Y, Zhu R, Liu B, Wang W, Yang P, Cao Z, Yang X, Du W, Yang Q, Liang J, Hu J, Ma G
Frontiers in pharmacology 2022
Beneficial Effect of Fenofibrate and Silymarin on Hepatic Steatosis and Gene Expression of Lipogenic and Cytochrome P450 Enzymes in Non-Obese Hereditary Hypertriglyceridemic Rats
Vecera R, Poruba M, Hüttl M, Malinska H, Oliyarnyk O, Markova I, Racova Z, Soukop J, Kazdova L
Current issues in molecular biology 2022
Functional and Structural Insights into Human PPARα/δ/γ Subtype Selectivity of Bezafibrate, Fenofibric Acid, and Pemafibrate
Honda A, Kamata S, Akahane M, Machida Y, Uchii K, Shiiyama Y, Habu Y, Miyawaki S, Kaneko C, Oyama T, Ishii I
International journal of molecular sciences 2022
The lncRNA MIAT regulates CPT-1a mediated cardiac hypertrophy through m6A RNA methylation reading protein Ythdf2
Yang Y, Mbikyo MB, Zhang J, Zhang Y, Zhang N, Li Z
Cell Death Discovery 2022
Oleoylethanolamide Alleviates Hepatic Ischemia-Reperfusion Injury via Inhibiting Endoplasmic Reticulum Stress-Associated Apoptosis
Qi S, Yan Q, Wang Z, Liu D, Zhan M, Du J, Chen L
PPAR Research 2022
ABCC6 Knockdown Fuels Cell Proliferation by Regulating PPARα in Hepatocellular Carcinoma
Zhao Z, Zhao Z, Wang J, Zhang H, Xi Z, Xia Q
Frontiers in Oncology 2022
Probiotics counteract hepatic steatosis caused by ketogenic diet and upregulate AMPK signaling in a model of infantile epilepsy
Mu C, Nikpoor N, Tompkins TA, Rho JM, Scantlebury MH, Shearer J
EBioMedicine 2022
A Network Pharmacology Study on the Active Components and Targets of the Radix Ginseng and Radix Bupleuri Herb Pair for Treating Nonalcoholic Fatty Liver Disease
Zhang Q, Zhang L, Liu K, Shang H, Ruan J, Yu Z, Meng S, Liang F, Wang T, Zhang H, Peng W, Wang Y, Chen J, Xiao T, Wang B
Evidence-based complementary and alternative medicine : eCAM 2022
Comprehensive Analysis of Long Non-coding RNA and mRNA Transcriptomes Related to Hypoxia Adaptation in Tibetan Sheep
Lu Z, Yuan C, Li J, Guo T, Yue Y, Niu C, Liu J, Yang B
Frontiers in Veterinary Science 2022
Hepatic MIR20B promotes nonalcoholic fatty liver disease by suppressing PPARA
Y Lee, H Jang, S Kim, S Choi, K Khim, H Eom, J Hyun, K Shin, Y Chae, H Kim, J Park, N Park, C Woo, C Hong, E Koh, D Nam, J Choi
eLife 2021
Roles of MicroRNAs in Glucose and Lipid Metabolism in the Heart
H Du, Y Zhao, H Li, DW Wang, C Chen
Frontiers in Cardiovascular Medicine 2021
Regulation of chicken vanin1 gene expression by peroxisome proliferators activated receptor α and miRNA-181a-5p
Z Wang, J Yu, N Hua, J Li, L Xu, W Yao, Z Gu
2021
Deficiency of peroxisome proliferator-activated receptor α attenuates apoptosis and promotes migration of vascular smooth muscle cells
Y Duan, D Qi, Y Liu, Y Song, X Wang, S Jiao, H Li, FJ Gonzalez, Y Qi, Q Xu, J Du, A Qu
Biochemistry and Biophysics Reports 2021
Polygonum multiflorum Thunb. Hot Water Extract Reverses High-Fat Diet-Induced Lipid Metabolism of White and Brown Adipose Tissues in Obese Mice
RY Choi, MK Lee
Plants 2021
Hypoxia via ERK Signaling Inhibits Hepatic PPARα to Promote Fatty Liver
RG Mooli, J Rodriguez, S Takahashi, S Solanki, FJ Gonzalez, SK Ramakrishnan, YM Shah
CMGH Cellular and Molecular Gastroenterology and Hepatology 2021
Fish Oil Increases Diet-Induced Thermogenesis in Mice
T Yamazaki, D Li, R Ikaga
Marine drugs 2021
The effectiveness of plasma miR‑33a‑5p as a predictive biomarker for the efficacy of colorectal cancer chemotherapy
M Sasaki, T Ishikawa, M Ishiguro, S Okazaki, S Yamauchi, A Kikuchi, T Matsuyama, K Kawada, M Tokunaga, H Uetake, Y Kinugasa
Oncology Letters 2021
Intrauterine Programming of Cardiovascular Diseases in Maternal Diabetes
R Higa, ML Leonardi, A Jawerbaum
Frontiers in physiology 2021
Selective Peroxisome Proliferator-Activated Receptor Alpha Modulators (SPPARMα) in the Metabolic Syndrome: Is Pemafibrate Light at the End of the Tunnel?
JC Fruchart, MP Hermans, J Fruchart-Najib, T Kodama
Current Atherosclerosis Reports 2021
Role of Peroxisome Proliferator-Activated Receptors (PPARs) in Energy Homeostasis of Dairy Animals: Exploiting Their Modulation through Nutrigenomic Interventions
F Hassan, A Nadeem, Z Li, M Javed, Q Liu, J Azhar, MS Rehman, K Cui, S ur Rehman
International journal of molecular sciences 2021
Regulation of cold-induced thermogenesis by the RNA binding protein FAM195A
J Cannavino, M Shao, YA An, S Bezprozvannaya, S Chen, J Kim, L Xu, JR McAnally, PE Scherer, N Liu, RK Gupta, R Bassel-Duby, EN Olson
Proceedings of the National Academy of Sciences 2021
Oxidative Stress, Kinase Activation, and Inflammatory Pathways Involved in Effects on Smooth Muscle Cells During Pulmonary Artery Hypertension Under Hypobaric Hypoxia Exposure
P Siques, E Pena, J Brito, SE Alam
Frontiers in physiology 2021
The role of peroxisome proliferator-activated receptors in healthy and diseased eyes
P Escandon, B Vasini, AE Whelchel, SE Nicholas, HG Matlock, JX Ma, D Karamichos
Experimental Eye Research 2021
YAP-TEAD mediates PPAR α–induced hepatomegaly and liver regeneration in mice
Fan S, Gao Y, Qu A, Jiang Y, Li H, Xie G, Yao X, Yang X, Zhu S, Yagai T, Tian J, Wang R, Gonzalez FJ, Huang M, Bi H
Hepatology 2021
Combinations of peptides synergistically activate the regenerative capacity of skin cells in vitro
Flagler MJ, Tamura M, Laughlin T, Hartman S, Ashe J, Adams R, Kozak K, Cresswell K, Mullins L, Jarrold BB, Isfort RJ, Sherrill JD
International Journal of Cosmetic Science 2021
Pemafibrate Ameliorates Liver Dysfunction and Fatty Liver in Patients with Non-Alcoholic Fatty Liver Disease with Hypertriglyceridemia: A Retrospective Study with the Outcome after a Mid-Term Follow-Up
Ikeda S, Sugihara T, Kihara T, Matsuki Y, Nagahara T, Takata T, Kitao S, Okura T, Yamamoto K, Isomoto H
Diagnostics 2021
Cargo proteins in extracellular vesicles: potential for novel therapeutics in non-alcoholic steatohepatitis
Kim J, Lee SK, Jeong SY, Cho HJ, Park J, Kim TM, Kim S
Journal of nanobiotechnology 2021
Dietary Lipids and Dyslipidemia in Chronic Kidney Disease
Kochan Z, Szupryczynska N, Malgorzewicz S, Karbowska J
Nutrients 2021
PPARα Gene Is Involved in Body Composition Variation in Response to an Aerobic Training Program in Overweight/Obese
Cardoso GA, Ribeiro MD, Sousa BR, de Oliveira Y, Sena KF, Batista JR, Almeida AE, Filho JM, Silva RS, Persuhn DC, Silva AS
PPAR Research 2021
Human amniotic mesenchymal stem cells-conditioned medium protects mice from high-fat diet-induced obesity
Tan HL, Guan XH, Hu M, Wu J, Li RZ, Wang LF, Huang HD, Yu ZP, Wang XY, Xiao YF, Deng KY, Xin HB
Stem Cell Research & Therapy 2021
Effects of Bacillus Subtilis-Fermented White Sword Bean Extract on Adipogenesis and Lipolysis of 3T3-L1 Adipocytes
Choi Y, Kim DS, Lee MC, Park S, Lee JW, Om AS
Foods 2021
P- Hydroxybenzyl Alcohol Alleviates Oxidative Stress in a Nonalcoholic Fatty Liver Disease Larval Zebrafish Model and a BRL-3A Hepatocyte Via the Nrf2 Pathway
An J, Cheng L, Yang L, Song N, Zhang J, Ma K, Ma J
Frontiers in pharmacology 2021
Biomarkers and key pathways in atrial fibrillation associated with mitral valve disease identified by multi-omics study
Li MY, Chen HX, Hou HT, Wang J, Liu XC, Yang Q, He GW
Annals of translational medicine 2021
Alport syndrome: Proteomic analysis identifies early molecular pathway alterations in Col4a3 knock out mice
O Nicolaou, A Kousios, K Sokratous, L Potamiti, L Koniali, G Neophytou, R Papacharalampous, M Zanti, K Ioannou, A Hadjisavvas, C Stingl, TM Luider, K Kyriacou
Nephrology (Carlton, Vic.) 2020
Circadian Rhythm in Adipose Tissue: Novel Antioxidant Target for Metabolic and Cardiovascular Diseases
AW Man, N Xia, H Li
Antioxidants 2020
Therapeutic Approaches to Treat Mitochondrial Diseases: “One-Size-Fits-All” and “Precision Medicine” Strategies
E Bottani, C Lamperti, A Prigione, V Tiranti, N Persico, D Brunetti
Pharmaceutics 2020
Peripheral circadian rhythms in the liver and white adipose tissue of mice are attenuated by constant light and restored by time-restricted feeding
D Yamamuro, M Takahashi, S Nagashima, T Wakabayashi, H Yamazaki, A Takei, S Takei, K Sakai, K Ebihara, Y Iwasaki, T Yada, S Ishibashi, H Guillou
PloS one 2020
Influences of glycyrrhetinic acid (GA) dietary supplementation on growth, feed utilization, and expression of lipid metabolism genes in channel catfish (Ictalurus punctatus) fed a high-fat diet
HE Desouky, G Jiang, D Zhang, KP Abasubong, X Yuan, X Li, W Liu
Fish Physiology and Biochemistry 2020
Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases
J Decara, P Rivera, AJ López-Gambero, A Serrano, FJ Pavón, E Baixeras, FR de Fonseca, J Suárez
Frontiers in pharmacology 2020
Antihyperglycemic Effects and Mode of Actions of Musa paradisiaca Leaf and Fruit Peel Hydroethanolic Extracts in Nicotinamide/Streptozotocin-Induced Diabetic Rats
SM Aziz, OM Ahmed, SM EL-Twab, HM Al-Muzafar, KA Amin, M Abdel-Gabbar
Evidence-Based Complementary and Alternative Medicine 2020
PPARα activation directly upregulates thrombomodulin in the diabetic retina
A Shiono, H Sasaki, R Sekine, Y Abe, Y Matsumura, T Inagaki, T Tanaka, T Kodama, H Aburatani, J Sakai, H Takagi
Scientific Reports 2020
Pemafibrate, a New Selective PPARα Modulator: Drug Concept and Its Clinical Applications for Dyslipidemia and Metabolic Diseases
S Yamashita, D Masuda, Y Matsuzawa
Current Atherosclerosis Reports 2020
Non-coding RNAs: the new central dogma of cancer biology
PE Saw, X Xu, J Chen, EW Song
Science China Life Sciences 2020
Leveraging Nuclear Receptors as Targets for Pathological Ocular Vascular Diseases
PL Yao, J Peavey, G Malek
International journal of molecular sciences 2020
PPARα Agonist Oral Therapy in Diabetic Retinopathy
Y Tomita, D Lee, K Tsubota, T Kurihara
Biomedicines 2020
Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors
S Francque, G Szabo, MF Abdelmalek, CD Byrne, K Cusi, JF Dufour, M Roden, F Sacks, F Tacke
Nature Reviews Gastroenterology & Hepatology 2020
PPAR Beta/Delta and the Hallmarks of Cancer
N Wagner, KD Wagner
Cells 2020
Protective and Detrimental Roles of p38α MAPK in Different Stages of Nonalcoholic Fatty Liver Disease
Hwang S, Wang X, Rodrigues RM, Ma J, He Y, Seo W, Park SH, Kim SJ, Feng D, Gao B
Hepatology 2020
Pemafibrate decreases markers of hepatic inflammation in patients with non-alcoholic fatty liver disease
Shinozaki S, Tahara T, Lefor AK, Ogura M
Clinical and Experimental Hepatology 2020
miRNAs as Novel Biomarkers of Chronic Kidney Injury in Anabolic-Androgenic Steroid Users: An Experimental Study
Sessa F, Salerno M, Bertozzi G, Cipolloni L, Messina G, Aromatario M, Polo L, Turillazzi E, Pomara C
Frontiers in pharmacology 2020
Mechanisms of action, chemical characteristics, and model systems of obesogens
Griffin MD, Pereira SR, DeBari MK, Abbott RD
2020
Selective Peroxisome Proliferator–Activated Receptor Alpha Modulators (SPPARMα): New Opportunities to Reduce Residual Cardiovascular Risk in Chronic Kidney Disease?
Fruchart JC, Hermans MP, Fruchart-Najib J
Current Atherosclerosis Reports 2020
Multifaceted deregulation of gene expression and protein synthesis with age
Anisimova AS, Meerson MB, Gerashchenko MV, Kulakovskiy IV, Dmitriev SE, Gladyshev VN
Proceedings of the National Academy of Sciences 2020
Anti-hyperglycemic and hypolipidemic effects of black ginseng extract containing increased Rh4, Rg5, and Rk1 content in muscle and liver of type 2 diabetic db/db mice
Jeong YJ, Hwang MJ, Hong CO, Yoo DS, Kim JS, Kim DY, Lee KW
Food Science and Biotechnology 2020
Structural Basis for PPARα Activation by 1H-pyrazolo-[3,4-b]pyridine Derivatives
Yoshida T, Oki H, Doi M, Fukuda S, Yuzuriha T, Tabata R, Ishimoto K, Kawahara K, Ohkubo T, Miyachi H, Doi T, Tachibana K
Scientific Reports 2020
Pirfenidone Is an Agonistic Ligand for PPARα and Improves NASH by Activation of SIRT1/LKB1/pAMPK
Sandoval\u2010Rodriguez A, Monroy\u2010Ramirez HC, Meza\u2010Rios A, Garcia\u2010Bañuelos J, Vera\u2010Cruz J, Gutiérrez\u2010Cuevas J, Silva\u2010Gomez J, Staels B, Dominguez\u2010Rosales J, Galicia\u2010Moreno M, Vazquez\u2010Del Mercado M, Navarro\u2010Partida J, Santos\u2010Garcia A, Armendariz\u2010Borunda J
Hepatology Communications 2020
Lifestyle and Food Habits Impact on Chronic Diseases: Roles of PPARs
M dAngelo, V Castelli, MG Tupone, M Catanesi, A Antonosante, R Dominguez-Benot, R Ippoliti, AM Cimini, E Benedetti
International journal of molecular sciences 2019
Endocannabinoid System in Hepatic Glucose Metabolism, Fatty Liver Disease, and Cirrhosis
I Bazwinsky-Wutschke, A Zipprich, F Dehghani
International journal of molecular sciences 2019
Targeting Myeloid-Derived Cells: New Frontiers in the Treatment of Non-alcoholic and Alcoholic Liver Disease
L Vonghia, MA Herck, J Weyler, S Francque
Frontiers in immunology 2019
CircRNAs in cancer metabolism: a review
T Yu, Y Wang, Y Fan, N Fang, T Wang, T Xu, Y Shu
Journal of Hematology & Oncology 2019
The historical context and scientific legacy of John O. Holloszy
JM Hagberg, EF Coyle, KM Baldwin, GD Cartee, L Fontana, MJ Joyner, JP Kirwan, DR Seals, EP Weiss
Journal of applied physiology 2019
Hepatocyte-specific loss of GPS2 in mice reduces non-alcoholic steatohepatitis via activation of PPARα
N Liang, A Damdimopoulos, S Goñi, Z Huang, LL Vedin, T Jakobsson, M Giudici, O Ahmed, M Pedrelli, S Barilla, F Alzaid, A Mendoza, T Schröder, R Kuiper, P Parini, A Hollenberg, P Lefebvre, S Francque, LV Gaal, B Staels, N Venteclef, E Treuter, R Fan
Nature Communications 2019
Neuroprotective effects of PPARα in retinopathy of type 1 diabetes
EA Pearsall, R Cheng, S Matsuzaki, K Zhou, L Ding, B Ahn, M Kinter, KM Humphries, AB Quiambao, RA Farjo, J Ma, LP Singh
PloS one 2019
Dehydroepiandrosterone on metabolism and the cardiovascular system in the postmenopausal period
CJ Teixeira, K Veras, CR de Oliveira Carvalho
Journal of Molecular Medicine 2019
Proximal tubule cyclophilin D regulates fatty acid oxidation in cisplatin-induced acute kidney injury
Jang HS, Noh MR, Jung EM, Kim WY, Southekal S, Guda C, Foster KW, Oupicky D, Ferrer FA, Padanilam BJ
Kidney International 2019
Peroxisome Proliferator-Activated Receptors and Their Agonists in Nonalcoholic Fatty Liver Disease
Choudhary NS, Kumar N, Duseja A
Journal of Clinical and Experimental Hepatology 2019
Inhibition Effect of Triglyceride Accumulation by Large Yellow Croaker Roe DHA-PC in HepG2 Cells
Lu X, Zhong R, Sun H, Zheng B, Chen L, Miao S, Liang P
Marine drugs 2019
The effects of PPAR-γ agonist pioglitazone on hippocampal cytokines, brain-derived neurotrophic factor, memory impairment, and oxidative stress status in lipopolysaccharide-treated rats
Beheshti F, Hosseini M, Hashemzehi M, Soukhtanloo M, Khazaei M, Shafei MN
Iranian Journal of Basic Medical Sciences 2019
Hepatocyte Peroxisome Proliferator–Activated Receptor α Enhances Liver Regeneration after Partial Hepatectomy in Mice
Xie G, Yin S, Zhang Z, Qi D, Wang X, Kim D, Yagai T, Brocker CN, Wang Y, Gonzalez FJ, Wang H, Qu A
The American Journal of Pathology 2019
Local In Vivo Measures of Muscle Lipid and Oxygen Consumption Change in Response to Combined Vitamin D Repletion and Aerobic Training in Older Adults.
Thomas DT, Schnell DM, Redzic M, Zhao M, Abraha H, Jones D, Brim H, Yu G
Nutrients 2019
A Molecular Dynamics Approach to Explore the Intramolecular Signal Transduction of PPAR-α.
Basith S, Manavalan B, Shin TH, Lee G
International journal of molecular sciences 2019
Mitochondrial Genetic Disorders: Cell Signaling and Pharmacological Therapies.
Djouadi F, Bastin J
Cells 2019
Elovl4a participates in LC-PUFA biosynthesis and is regulated by PPARαβ in golden pompano Trachinotus ovatus (Linnaeus 1758).
Zhu KC, Song L, Guo HY, Guo L, Zhang N, Liu BS, Jiang SG, Zhang DC
Scientific Reports 2019
Impairment of PPAR α and the Fatty Acid Oxidation Pathway Aggravates Renal Fibrosis during Aging
KW Chung, EK Lee, MK Lee, GT Oh, BP Yu, HY Chung
Journal of the American Society of Nephrology : JASN 2018
A novel ASBT inhibitor, IMB17-15, repressed nonalcoholic fatty liver disease development in high-fat diet-fed Syrian golden hamsters
M Ge, W Niu, J Ren, S Cai, D Yu, H Liu, N Zhang, Y Zhang, Y Wang, R Shao, J Wang, H He
Acta Pharmacologica Sinica 2018
Changes of the Fatty Acid Profile in Erythrocyte Membranes of Patients following 6-Month Dietary Intervention Aimed at the Regression of Nonalcoholic Fatty Liver Disease (NAFLD)
D Maciejewska, W Marlicz, K Ryterska, M Banaszczak, D Jamioł-Milc, E Stachowska
Canadian journal of gastroenterology & hepatology 2018
mTORC Inhibitors as Broad-Spectrum Therapeutics for Age-Related Diseases
H Walters, L Cox
International journal of molecular sciences 2018
Peroxisome proliferator-activated receptor α attenuates high-cholesterol diet-induced toxicity and pro-thrombotic effects in mice
Y Lu, M Harada, Y Kamijo, T Nakajima, N Tanaka, E Sugiyama, M Kyogashima, FJ Gonzalez, T Aoyama
Archives of Toxicology 2018
Lipid metabolism and lipophagy in cancer
M Maan, JM Peters, M Dutta, AD Patterson
Biochemical and Biophysical Research Communications 2018
Mice lacking RAP1 show early onset and higher rates of DEN-induced hepatocellular carcinomas in female mice
I Ferrara-Romeo, P Martínez, MA Blasco, AJ Lustig
PloS one 2018
The circadian clock in white and brown adipose tissue: mechanistic, endocrine and clinical aspects
O Froy, M Garaulet
Endocrine reviews 2018
Pycnogenol® Induces Browning of White Adipose Tissue through the PKA Signaling Pathway in Apolipoprotein E-Deficient Mice
H Cong, W Zhong, Y Wang, S Ikuyama, B Fan, J Gu
Journal of Diabetes Research 2018
Integrative analysis of microRNAs and mRNAs revealed regulation of composition and metabolism in Nelore cattle
GB Oliveira, LC Regitano, AS Cesar, JM Reecy, KY Degaki, MD Poleti, AM Felício, JE Koltes, LL Coutinho
BMC Genomics 2018
Pivotal Roles of Peroxisome Proliferator-Activated Receptors (PPARs) and Their Signal Cascade for Cellular and Whole-Body Energy Homeostasis
S Lamichane, BD Lamichane, SM Kwon
International journal of molecular sciences 2018
Hepatic PPARα function is controlled by polyubiquitination and proteasome-mediated degradation through the coordinated actions of PAQR3 and HUWE1
Z Zhao, D Xu, Z Wang, L Wang, R Han, Z Wang, L Liao, Y Chen
Hepatology 2018
Identification of a Novel PPAR-γ Agonist through a Scaffold Tuning Approach.
Gim HJ, Choi YS, Li H, Kim YJ, Ryu JH, Jeon R
International journal of molecular sciences 2018
Identification of Fatty Acid Desaturase 6 in Golden Pompano Trachinotus Ovatus (Linnaeus 1758) and Its Regulation by the PPARαb Transcription Factor.
Zhu KC, Song L, Guo HY, Guo L, Zhang N, Liu BS, Jiang SG, Zhang DC
International journal of molecular sciences 2018
Role of peroxisome proliferator-activated receptors in non-alcoholic fatty liver disease inflammation.
Silva AKS, Peixoto CA
Cellular and molecular life sciences : CMLS 2018
Pharmacogenetics of posttransplant diabetes mellitus
P Lancia, TA de Beaumais, E Jacqz-Aigrain
The Pharmacogenomics Journal 2017
PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part I: PPAR-α
L Han, WJ Shen, S Bittner, FB Kraemer, S Azhar
Future Cardiology 2017
PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part II: PPAR-β/δ and PPAR-γ
L Han, WJ Shen, S Bittner, FB Kraemer, S Azhar
Future Cardiology 2017
Administration of mesenchymal stromal cells before renal ischemia/reperfusion attenuates kidney injury and may modulate renal lipid metabolism in rats
P Erpicum, P Rowart, L Poma, JM Krzesinski, O Detry, F Jouret
Scientific Reports 2017
Exchange of polar lipids from adults to neonates in Daphnia magna: Perturbations in sphingomyelin allocation by dietary lipids and environmental toxicants
N Sengupta, DC Reardon, PD Gerard, WS Baldwin, SN Witt
PloS one 2017
Microparticles Carrying Peroxisome Proliferator-Activated Receptor Alpha Restore the Reduced Differentiation and Functionality of Bone Marrow-Derived Cells Induced by High-Fat Diet: MPs PPARα+/+ Restore Failed EPC Function
L Vergori, E Lauret, R Soleti, R Andriantsitohaina, MC Martinez
Stem Cells Translational Medicine 2017
Chiglitazar Preferentially Regulates Gene Expression via Configuration-Restricted Binding and Phosphorylation Inhibition of PPAR γ
DS Pan, W Wang, NS Liu, QJ Yang, K Zhang, JZ Zhu, S Shan, ZB Li, ZQ Ning, L Huang, XP Lu
PPAR Research 2017
Perspectives on Nonalcoholic Fatty Liver Disease: An Overview of Present and Future Therapies
J Vizuete, A Camero, M Malakouti, K Garapati, J Gutierrez
Journal of Clinical and Translational Hepatology 2017
TOR-mediated regulation of metabolism in aging
H Antikainen, M Driscoll, G Haspel, R Dobrowolski
Aging Cell 2017
MicroRNA-33a promotes cell proliferation and inhibits apoptosis by targeting PPARα in human hepatocellular carcinoma
W Chang, L Zhang, Y Xian, Z Yu
Experimental and therapeutic medicine 2017
The new-generation pan-peroxisome proliferator-activated receptor agonist IVA337 protects the liver from metabolic disorders and fibrosis: Hepatology Communications, Vol. XX, No. X, 2017
G Wettstein, JM Luccarini, L Poekes, P Faye, F Kupkowski, V Adarbes, E Defrêne, C Estivalet, X Gawronski, I Jantzen, A Philippot, J Tessier, P Tuyaa-Boustugue, F Oakley, DA Mann, I Leclercq, S Francque, I Konstantinova, P Broqua, JL Junien
Hepatology Communications 2017
Therapeutic Effects of a Novel Agonist of Peroxisome Proliferator-Activated Receptor Alpha for the Treatment of Diabetic Retinopathy
G Deng, EP Moran, R Cheng, G Matlock, K Zhou, D Moran, D Chen, Q Yu, JX Ma
Investigative ophthalmology & visual science 2017
Fenofibrate, but not ezetimibe, prevents fatty liver disease in mice lacking phosphatidylethanolamine N -methyltransferase
JN van der Veen, S Lingrell, X Gao, A Takawale, Z Kassiri, DE Vance, RL Jacobs
Journal of lipid research 2017
Transcriptome analysis of mRNA and microRNAs in intramuscular fat tissues of castrated and intact male Chinese Qinchuan cattle
YY Zhang, HB Wang, YN Wang, HC Wang, S Zhang, JY Hong, HF Guo, D Chen, Y Yang, LS Zan, JJ Loor
PloS one 2017
Peroxisome Proliferator-Activated Receptors Associated with Nonalcoholic Fatty Liver Disease
N Wang, R Kong, H Luo, X Xu, J Lu
PPAR Research 2017
Pemafibrate, a novel selective peroxisome proliferator-activated receptor alpha modulator, improves the pathogenesis in a rodent model of nonalcoholic steatohepatitis
Honda Y, Kessoku T, Ogawa Y, Tomeno W, Imajo K, Fujita K, Yoneda M, Takizawa T, Saito S, Nagashima Y, Nakajima A
Scientific Reports 2017
PPARα is essential for retinal lipid metabolism and neuronal survival.
Pearsall EA, Cheng R, Zhou K, Takahashi Y, Matlock HG, Vadvalkar SS, Shin Y, Fredrick TW, Gantner ML, Meng S, Fu Z, Gong Y, Kinter M, Humphries KM, Szweda LI, Smith LEH, Ma JX
BMC Biology 2017
A comprehensive data mining study shows that most nuclear receptors act as newly proposed homeostasis-associated molecular pattern receptors.
Wang L, Nanayakkara G, Yang Q, Tan H, Drummer C, Sun Y, Shao Y, Fu H, Cueto R, Shan H, Bottiglieri T, Li YF, Johnson C, Yang WY, Yang F, Xu Y, Xi H, Liu W, Yu J, Choi ET, Cheng X, Wang H, Yang X
Journal of Hematology & Oncology 2017
Effects of stocking density on lipid deposition and expression of lipid-related genes in Amur sturgeon (Acipenser schrenckii).
Ren Y, Wen H, Li Y, Li J, He F, Ni M
Fish Physiology and Biochemistry 2017
The potential of natural products for targeting PPARα.
Rigano D, Sirignano C, Taglialatela-Scafati O
Acta pharmaceutica Sinica. B 2017
Saikosaponins induced hepatotoxicity in mice via lipid metabolism dysregulation and oxidative stress: a proteomic study.
Li X, Li X, Lu J, Huang Y, Lv L, Luan Y, Liu R, Sun R
BMC complementary and alternative medicine 2017
Gut commensal Bacteroides acidifaciens prevents obesity and improves insulin sensitivity in mice
JY Yang, YS Lee, Y Kim, SH Lee, S Ryu, S Fukuda, K Hase, CS Yang, HS Lim, MS Kim, HM Kim, SH Ahn, BE Kwon, HJ Ko, MN Kweon
Mucosal Immunology 2016
TGF- β 1/Smads and miR-21 in Renal Fibrosis and Inflammation
A Loboda, M Sobczak, A Jozkowicz, J Dulak
Mediators of Inflammation 2016
Hypoxia-regulated mechanisms in the pathogenesis of obesity and non-alcoholic fatty liver disease
S Lefere, CV Steenkiste, X Verhelst, HV Vlierberghe, L Devisscher, A Geerts
Cellular and Molecular Life Sciences 2016
Endothelial cell–cardiomyocyte crosstalk in diabetic cardiomyopathy
A Wan, B Rodrigues
Cardiovascular Research 2016
Protective Effect of Peroxisome Proliferator-Activated Receptor α Activation against Cardiac Ischemia-Reperfusion Injury Is Related to Upregulation of Uncoupling Protein-3
JW Song, HJ Kim, H Lee, J Kim, YL Kwak
Oxidative medicine and cellular longevity 2016
Microarray analysis of gene expression in liver, adipose tissue and skeletal muscle in response to chronic dietary administration of NDGA to high-fructose fed dyslipidemic rats
H Zhang, WJ Shen, Y Li, A Bittner, S Bittner, J Tabassum, YF Cortez, FB Kraemer, S Azhar
Nutrition & Metabolism 2016
Transient Hepatic Overexpression of Insulin-Like Growth Factor 2 Induces Free Cholesterol and Lipid Droplet Formation
SM Kessler, S Laggai, EV Wonterg, K Gemperlein, R Müller, J Haybaeck, RE Vandenbroucke, M Ogris, C Libert, AK Kiemer
Frontiers in physiology 2016
Obesity: Current and potential pharmacotherapeutics and targets
V Narayanaswami, LP Dwoskin
Pharmacology & Therapeutics 2016
The Selective SGLT2 Inhibitor Ipragliflozin Has a Therapeutic Effect on Nonalcoholic Steatohepatitis in Mice
Y Honda, K Imajo, T Kato, T Kessoku, Y Ogawa, W Tomeno, S Kato, H Mawatari, K Fujita, M Yoneda, S Saito, A Nakajima, P Aspichueta
PloS one 2016
Proteome Dynamics Reveals Pro-Inflammatory Remodeling of Plasma Proteome in a Mouse Model of NAFLD
L Li, G Bebek, SF Previs, JD Smith, RG Sadygov, AJ McCullough, B Willard, T Kasumov
Journal of Proteome Research 2016
Retinal lipid and glucose metabolism dictates angiogenesis through the lipid sensor Ffar1
JS Joyal, Y Sun, ML Gantner, Z Shao, LP Evans, N Saba, T Fredrick, S Burnim, JS Kim, G Patel, AM Juan, CG Hurst, CJ Hatton, Z Cui, KA Pierce, P Bherer, E Aguilar, MB Powner, K Vevis, M Boisvert, Z Fu, E Levy, M Fruttiger, A Packard, FA Rezende, B Maranda, P Sapieha, J Chen, M Friedlander, CB Clish, LE Smith
Nature Medicine 2016
GLP-1 receptor independent pathways: emerging beneficial effects of GLP-1 breakdown products
V Guglielmi, P Sbraccia
Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity 2016
Combined pharmacological activation of AMPK and PPAR δ potentiates the effects of exercise in trained mice
Manio MC, Inoue K, Fujitani M, Matsumura S, Fushiki T
Physiological Reports 2016
Type of supplemented simple sugar, not merely calorie intake, determines adverse effects on metabolism and aortic function in female rats.
Sangüesa G, Shaligram S, Akther F, Roglans N, Laguna JC, Rahimian R, Alegret M
American journal of physiology. Heart and circulatory physiology 2016
E(2)/ERβ Inhibits PPARα to Regulate Cell-Proliferation and Enhance Apoptosis in Hep3B-Hepatocellular Carcinoma.
Chang-Lee SN, Hsu HH, Shibu MA, Ho TJ, Tsai CH, Chen MC, Tu CC, Viswanadha VP, Kuo WW, Huang CY
Pathology oncology research : POR 2016
Astaxanthin as a Potential Protector of Liver Function: A Review.
Chen JT, Kotani K
Journal of clinical medicine research 2016
Peroxisome proliferator-activated receptor α-dependent renoprotection of murine kidney by irbesartan.
Harada M, Kamijo Y, Nakajima T, Hashimoto K, Yamada Y, Shimojo H, Gonzalez FJ, Aoyama T
Clinical science (London, England : 1979) 2016
Transcriptomic analysis of mouse liver reveals a potential hepato-enteric pathogenic mechanism in acute Toxoplasma gondii infection.
He JJ, Ma J, Elsheikha HM, Song HQ, Huang SY, Zhu XQ
Parasites & vectors 2016
Cyclin D1 represses peroxisome proliferator-activated receptor alpha and inhibits fatty acid oxidation.
Kamarajugadda S, Becker JR, Hanse EA, Mashek DG, Mashek MT, Hendrickson AM, Mullany LK, Albrecht JH
Oncotarget 2016
A Novel Peroxisome Proliferator-activated Receptor (PPAR)α Agonist and PPARγ Antagonist, Z-551, Ameliorates High-fat Diet-induced Obesity and Metabolic Disorders in Mice
Y Shiomi, T Yamauchi, M Iwabu, M Okada-Iwabu, R Nakayama, Y Orikawa, Y Yoshioka, K Tanaka, K Ueki, T Kadowaki
The Journal of biological chemistry 2015
PPARα Protein Expression Was Increased by Four Weeks of Intermittent Hypoxic Training via AMPKα2-Dependent Manner in Mouse Skeletal Muscle
G Li, J Wang, J Ye, Y Zhang, Y Zhang, J Peterson
PloS one 2015
Transcriptome Analysis of K-877 (a Novel Selective PPARα Modulator (SPPARMα))-Regulated Genes in Primary Human Hepatocytes and the Mouse Liver
S Raza-Iqbal, T Tanaka, M Anai, T Inagaki, Y Matsumura, K Ikeda, A Taguchi, FJ Gonzalez, J Sakai, T Kodama
Journal of Atherosclerosis and Thrombosis 2015
GLP-1(32-36)amide Pentapeptide Increases Basal Energy Expenditure and Inhibits Weight Gain in Obese Mice
E Tomas, V Stanojevic, K McManus, A Khatri, P Everill, WW Bachovchin, JF Habener
Diabetes 2015
Lipid metabolism and inflammation modulated by Vitamin D in liver of diabetic rats
C Ning, L Liu, G Lv, Y Yang, Y Zhang, R Yu, Y Wang, J Zhu
Lipids in Health and Disease 2015
Peroxisome Proliferator-Activated Receptors and the Heart: Lessons from the Past and Future Directions
WS Lee, J Kim
PPAR Research 2015
Keratin 8 absence down-regulates colonocyte HMGCS2 and modulates colonic ketogenesis and energy metabolism
TO Helenius, JO Misiorek, JH Nystrom, LE Fortelius, A Habtezion, J Liao, MN Asghar, H Zhang, S Azhar, MB Omary, DM Toivola
Molecular biology of the cell 2015
Expanding Roles for Lipid Droplets
MA Welte
Current Biology 2015
Alteration of Fatty Acid Oxidation in Tubular Epithelial Cells: From Acute Kidney Injury to Renal Fibrogenesis
N Simon, A Hertig
Frontiers in Medicine 2015
Attenuation of insulin resistance in rats by agmatine: role of SREBP-1c, mTOR and GLUT-2
MH Sharawy, MS El-Awady, N Megahed, NM Gameil
Naunyn-Schmiedeberg's Archives of Pharmacology 2015
PPARD +294C overrepresentation in general and long-lived population in China Bama longevity area and unique relationships between PPARD +294T/C polymorphism and serum lipid profiles.
Luo CY, Liu CW, Ge L, Pang GF, Yang M, Hu CY, Lv ZP, Chen NY, Li HY, Wu HY, Wang YY, Yin RX, Pan SL, Peng JH
Lipids in Health and Disease 2015
Therapeutic Effects of PPAR α on Neuronal Death and Microvascular Impairment.
Moran EP, Ma JX
PPAR Research 2015
Irisin and Myonectin Regulation in the Insulin Resistant Muscle: Implications to Adipose Tissue: Muscle Crosstalk
Gamas L, Matafome P, Seiça R
Journal of Diabetes Research 2015
Oleoylethanolamide, an endogenous PPAR-α ligand, attenuates liver fibrosis targeting hepatic stellate cells.
Chen L, Li L, Chen J, Li L, Zheng Z, Ren J, Qiu Y
Oncotarget 2015
Transgenic expression of omega-3 PUFA synthesis genes improves zebrafish survival during Vibrio vulnificus infection.
Cheng CL, Huang SJ, Wu CL, Gong HY, Ken CF, Hu SY, Wu JL
Journal of biomedical science 2015
Loss of 5-lipoxygenase activity protects mice against paracetamol-induced liver toxicity.
Pu S, Ren L, Liu Q, Kuang J, Shen J, Cheng S, Zhang Y, Jiang W, Zhang Z, Jiang C, He J
British Journal of Pharmacology 2015
Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPARα expression.
Loyer X, Paradis V, Hénique C, Vion AC, Colnot N, Guerin CL, Devue C, On S, Scetbun J, Romain M, Paul JL, Rothenberg ME, Marcellin P, Durand F, Bedossa P, Prip-Buus C, Baugé E, Staels B, Boulanger CM, Tedgui A, Rautou PE
Gut 2015
Circulating Very-Long-Chain Saturated Fatty Acids and Incident Coronary Heart Disease in US Men and Women.
Malik VS, Chiuve SE, Campos H, Rimm EB, Mozaffarian D, Hu FB, Sun Q
Circulation 2015
Periostin promotes liver steatosis and hypertriglyceridemia through downregulation of PPARalpha
Yan Lu, Xing Liu, Yang Jiao, Xuelian Xiong, E Wang, Xiaolin Wang, Zhijian Zhang, Huijie Zhang, Lingling Pan, Youfei Guan, Dongsheng Cai, Ning Guang, Xiaoying Li
Journal of Clinical Investigation 2014
Acute induction of uncoupling protein 1 by citrulline in cultured explants of white adipose tissue from lean and high-fat-diet-fed rats
N Joffin, AM Jaubert, J Bamba, R Barouki, P Noirez, C Forest
2014
REGULATION OF OBESITY AND INSULIN RESISTANCE BY NITRIC OXIDE
BE Sansbury, BG Hill
Free radical biology & medicine 2014
Vitamins & Hormones
BE Sansbury, BG Hill
Vitamins & Hormones 2014
Pathogenesis and therapeutic approaches for non-alcoholic fatty liver disease
H Yoon
World journal of hepatology 2014
Fibroblast growth factor 21 is induced upon cardiac stress and alters cardiac lipid homeostasis
MK Brahma, RC Adam, NM Pollak, D Jaeger, KA Zierler, N Pocher, R Schreiber, M Romauch, T Moustafa, S Eder, T Ruelicke, K Preiss-Landl, A Lass, R Zechner, G Haemmerle
Journal of lipid research 2014
The balancing act – PPAR- γ ’s roles at the maternal-fetal interface
L Kadam, HR Kohan-Ghadr, S Drewlo
Systems Biology in Reproductive Medicine 2014
Palmitoylethanolamide Prevents Metabolic Alterations and Restores Leptin Sensitivity in Ovariectomized Rats
GM Raso, A Santoro, R Russo, R Simeoli, O Paciello, CD Carlo, S Diano, A Calignano, R Meli
Endocrinology 2014
Validation of a Genomics-Based Hypothetical Adverse Outcome Pathway: 2,4-Dinitrotoluene Perturbs PPAR Signaling Thus Impairing Energy Metabolism and Exercise Endurance
MS Wilbanks, KA Gust, S Atwa, I Sunesara, D Johnson, CY Ang, SA Meyer, EJ Perkins
Toxicological Sciences 2014
The IGF2 mRNA binding protein p62/IGF2BP2-2 induces fatty acid elongation as a critical feature of steatosis
S Laggai, SM Kessler, S Boettcher, V Lebrun, K Gemperlein, E Lederer, IA Leclercq, R Mueller, RW Hartmann, J Haybaeck, AK Kiemer
Journal of lipid research 2014
KSRP Ablation Enhances Brown Fat Gene Program in White Adipose Tissue Through Reduced miR-150 Expression
CF Chou, YY Lin, HK Wang, X Zhu, M Giovarelli, P Briata, R Gherzi, WT Garvey, CY Chen
Diabetes 2014
Linalool is a PPAR  ligand that reduces plasma TG levels and rewires the hepatic transcriptome and plasma metabolome
H Jun, JH Lee, J Kim, Y Jia, KH Kim, KY Hwang, EJ Yun, KR Do, SJ Lee
Journal of lipid research 2014
Lysosome: regulator of lipid degradation pathways
C Settembre, A Ballabio
Trends in Cell Biology 2014
Roles of PPARγ/NF-κB signaling pathway in the pathogenesis of intrahepatic cholestasis of pregnancy
Y Zhang, L Hu, Y Cui, Z Qi, X Huang, L Cai, T Zhang, Y Yin, Z Lu, J Xiang
PloS one 2014
Bixin and Norbixin Have Opposite Effects on Glycemia, Lipidemia, and Oxidative Stress in Streptozotocin-Induced Diabetic Rats
M Roehrs, CG Figueiredo, MM Zanchi, GV Bochi, RN Moresco, A Quatrin, S Somacal, L Conte, T Emanuelli
International Journal of Endocrinology 2014
Novel genomic signals of recent selection in an Ethiopian population
F Tekola-Ayele, A Adeyemo, G Chen, E Hailu, A Aseffa, G Davey, MJ Newport, CN Rotimi
European Journal of Human Genetics 2014
Hepatic sirtuin 1 is dispensable for fibrate-induced peroxisome proliferator-activated receptor-  function in vivo
JA Bonzo, C Brocker, C Jiang, RH Wang, CX Deng, FJ Gonzalez
American journal of physiology. Endocrinology and metabolism 2014
Therapeutic Role of Ursolic Acid on Ameliorating Hepatic Steatosis and Improving Metabolic Disorders in High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease Rats
Li S, Meng F, Liao X, Wang Y, Sun Z, Guo F, Li X, Meng M, Li Y, Sun C
PloS one 2014
Peroxisome proliferator-activated receptors for hypertension
Usuda D, Kanda T
World journal of cardiology 2014
Influence of Fenofibrate Treatment on Triacylglycerides, Diacylglycerides and Fatty Acids in Fructose Fed Rats
Kopf T, Schaefer HL, Troetzmueller M, Koefeler H, Broenstrup M, Konovalova T, Schmitz G
PloS one 2014
Peroxisome proliferator activated receptor alpha inhibits hepatocarcinogenesis through mediating NF-κB signaling pathway.
Zhang N, Chu ES, Zhang J, Li X, Liang Q, Chen J, Chen M, Teoh N, Farrell G, Sung JJ, Yu J
Oncotarget 2014
PPARA intron polymorphism associated with power performance in 30-s anaerobic Wingate Test.
Petr M, Stastny P, Pecha O, Šteffl M, Šeda O, Kohlíková E
PloS one 2014
Differential effects of omega-3 fatty acid docosahexaenoic acid and palmitate on the circadian transcriptional profile of clock genes in immortalized hypothalamic neurons.
Greco JA, Oosterman JE, Belsham DD
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology 2014
Sox17 regulates liver lipid metabolism and adaptation to fasting.
Rommelaere S, Millet V, Vu Manh TP, Gensollen T, Andreoletti P, Cherkaoui-Malki M, Bourges C, Escalière B, Du X, Xia Y, Imbert J, Beutler B, Kanai Y, Malissen B, Malissen M, Tailleux A, Staels B, Galland F, Naquet P
PloS one 2014
Bile acid-regulated peroxisome proliferator-activated receptor-α (PPARα) activity underlies circadian expression of intestinal peptide absorption transporter PepT1/Slc15a1.
Okamura A, Koyanagi S, Dilxiat A, Kusunose N, Chen JJ, Matsunaga N, Shibata S, Ohdo S
The Journal of biological chemistry 2014
Role of Glitazars in atherogenic dyslipidemia and diabetes: Two birds with one stone?
Munigoti SP, Harinarayan CV
Indian journal of endocrinology and metabolism 2014
Recovery of brain biomarkers following peroxisome proliferator-activated receptor agonist neuroprotective treatment before ischemic stroke.
Gelé P, Vingtdeux V, Potey C, Drobecq H, Ghestem A, Melnyk P, Buée L, Sergeant N, Bordet R
Proteome Science 2014
Giardia muris infection in mice is associated with a protective interleukin 17A response and induction of peroxisome proliferator-activated receptor alpha.
Dreesen L, De Bosscher K, Grit G, Staels B, Lubberts E, Bauge E, Geldhof P
Infection and immunity 2014
Protective and antioxidant effects of PPARα in the ischemic retina.
Moran E, Ding L, Wang Z, Cheng R, Chen Q, Moore R, Takahashi Y, Ma JX
Investigative ophthalmology & visual science 2014
Vitamin D status is related to intramyocellular lipid in older adults.
Redzic M, Powell DK, Thomas DT
Endocrine 2014
Effect of obesity on the association between common variations in the PPAR gene and C-reactive protein level in Chinese Han population.
Gu SJ, Chen DH, Guo ZR, Zhou ZY, Hu XS, Wu M
Endocrine 2014
Inverse association of colorectal cancer prevalence to serum levels of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in a large Appalachian population.
Innes KE, Wimsatt JH, Frisbee S, Ducatman AM
BMC Cancer 2014
Nuclear receptors in bone physiology and diseases
Y Imai, MY Youn, K Inoue, I Takada, A Kouzmenko, S Kato
Physiological reviews 2013
Gene expression profile analysis of type 2 diabetic mouse liver
F Zhang, X Xu, Y Zhang, B Zhou, Z He, Q Zhai
PloS one 2013
Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes
R Kones
Vascular Health and Risk Management 2013
Regulation of mTORC1 and its impact on gene expression at a glance
M Laplante, DM Sabatini
Journal of cell science 2013
Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME
P Godoy, NJ Hewitt, U Albrecht, ME Andersen, N Ansari, S Bhattacharya, JG Bode, J Bolleyn, C Borner, J Böttger, A Braeuning, RA Budinsky, B Burkhardt, NR Cameron, G Camussi, CS Cho, YJ Choi, JC Rowlands, U Dahmen, G Damm, O Dirsch, MT Donato, J Dong, S Dooley, D Drasdo, R Eakins, KS Ferreira, V Fonsato, J Fraczek, R Gebhardt, A Gibson, M Glanemann, CE Goldring, MJ Gómez-Lechón, GM Groothuis, L Gustavsson, C Guyot, D Hallifax, S Hammad, A Hayward, D Häussinger, C Hellerbrand, P Hewitt, S Hoehme, HG Holzhütter, JB Houston, J Hrach, K Ito, H Jaeschke, V Keitel, JM Kelm, BK Park, C Kordes, GA Kullak-Ublick, EL LeCluyse, P Lu, J Luebke-Wheeler, A Lutz, DJ Maltman, M Matz-Soja, P McMullen, I Merfort, S Messner, C Meyer, J Mwinyi, DJ Naisbitt, AK Nussler, P Olinga, F Pampaloni, J Pi, L Pluta, SA Przyborski, A Ramachandran, V Rogiers, C Rowe, C Schelcher, K Schmich, M Schwarz, B Singh, EH Stelzer, B Stieger, R Stöber, Y Sugiyama, C Tetta, WE Thasler, T Vanhaecke, M Vinken, TS Weiss, A Widera, CG Woods, JJ Xu, KM Yarborough, JG Hengstler
Archives of Toxicology 2013
In Vivo Actions of Peroxisome Proliferator-Activated Receptors: Glycemic control, insulin sensitivity, and insulin secretion
R Eldor, RA DeFronzo, M Abdul-Ghani
Diabetes care 2013
Loss of β-carotene 15,15’-oxygenase in developing mouse tissues alters esterification of retinol, cholesterol and diacylglycerols
JL Dixon, YK Kim, A Brinker, L Quadro
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2013
Hypoxia downregulates PPARγ via an ERK1/2–NF-κB–Nox4-dependent mechanism in human pulmonary artery smooth muscle cells
X Lu, KM Bijli, A Ramirez, TC Murphy, J Kleinhenz, CM Hart
Free radical biology & medicine 2013
RAP1 Protects from Obesity through Its Extratelomeric Role Regulating Gene Expression
P Martínez, G Gómez-López, F García, E Mercken, S Mitchell, JM Flores, R de Cabo, MA Blasco
Cell Reports 2013
The Role of PPARs in Placental Immunology: A Systematic Review of the Literature
S Hutter, J Knabl, U Andergassen, U Jeschke
PPAR Research 2013
Compare the effect of eicosapentaenoic acid and oxidized low-density lipoprotein on the expression of CD36 and peroxisome proliferator-activated receptor gamma.
Babaahmadi Rezaei H, Doosti M, Aminian M, Shabani P
Iranian Biomedical Journal 2013
Interferon regulatory factor 9 protects against hepatic insulin resistance and steatosis in male mice
XA Wang, R Zhang, D Jiang, W Deng, S Zhang, S Deng, J Zhong, T Wang, LH Zhu, L Yang, S Hong, S Guo, K Chen, XF Zhang, Z She, Y Chen, Q Yang, XD Zhang, H Li
Hepatology 2013
Inhibitors of Fatty Acid Synthesis Induce PPAR α -Regulated Fatty Acid β -Oxidative Genes: Synergistic Roles of L-FABP and Glucose
H Huang, AL McIntosh, GG Martin, AD Petrescu, KK Landrock, D Landrock, AB Kier, F Schroeder
PPAR Research 2013
Tissue-specific 5' heterogeneity of PPARα transcripts and their differential regulation by leptin
ES Garratt, MH Vickers, PD Gluckman, MA Hanson, GC Burdge, KA Lillycrop
PloS one 2013
SIRT4 represses peroxisome proliferator-activated receptor α activity to suppress hepatic fat oxidation
G Laurent, VC de Boer, LW Finley, M Sweeney, H Lu, TT Schug, Y Cen, SM Jeong, X Li, AA Sauve, MC Haigis
Molecular and cellular biology 2013
PPAR-α as a key nutritional and environmental sensor for metabolic adaptation
AV Contreras, N Torres, AR Tovar
Advances in nutrition (Bethesda, Md.) 2013
Dual Peroxisome Proliferator-Activated Receptor  /  Agonist GFT505 Improves Hepatic and Peripheral Insulin Sensitivity in Abdominally Obese Subjects
B Cariou, R Hanf, S Lambert-Porcheron, Y Zair, V Sauvinet, B Noel, L Flet, H Vidal, B Staels, M Laville
Diabetes care 2013
An update on the molecular actions of fenofibrate and its clinical effects on diabetic retinopathy and other microvascular end points in patients with diabetes.
Noonan JE, Jenkins AJ, Ma JX, Keech AC, Wang JJ, Lamoureux EL
Diabetes 2013
Assessment of inflammatory resilience in healthy subjects using dietary lipid and glucose challenges.
Wopereis S, Wolvers D, van Erk M, Gribnau M, Kremer B, van Dorsten FA, Boelsma E, Garczarek U, Cnubben N, Frenken L, van der Logt P, Hendriks HF, Albers R, van Duynhoven J, van Ommen B, Jacobs DM
BMC Medical Genomics 2013
Extracts of pomelo peels prevent high-fat diet-induced metabolic disorders in c57bl/6 mice through activating the PPARα and GLUT4 pathway.
Ding X, Guo L, Zhang Y, Fan S, Gu M, Lu Y, Jiang D, Li Y, Huang C, Zhou Z
PloS one 2013
Impaired transcriptional response of the murine heart to cigarette smoke in the setting of high fat diet and obesity.
Tilton SC, Karin NJ, Webb-Robertson BJ, Waters KM, Mikheev V, Lee KM, Corley RA, Pounds JG, Bigelow DJ
Chemical Research in Toxicology 2013
Endothelial Cells and Astrocytes: A Concerto en Duo in Ischemic Pathophysiology
V Berezowski, AM Fukuda, R Cecchelli, J Badaut
International Journal of Cell Biology 2012
Treatment with ginger ameliorates fructose-induced Fatty liver and hypertriglyceridemia in rats: modulation of the hepatic carbohydrate response element-binding protein-mediated pathway
H Gao, T Guan, C Li, G Zuo, J Yamahara, J Wang, Y Li
Evidence-Based Complementary and Alternative Medicine 2012
Gadd45α: a novel diabetes-associated gene potentially linking diabetic cardiomyopathy and baroreflex dysfunction
N Wang, C Yang, F Xie, L Sun, X Su, Y Wang, R Wei, R Zhang, X Li, B Yang, J Ai
PloS one 2012
mTOR, metabolism, and the regulation of T-cell differentiation and function
AT Waickman, JD Powell
Immunological Reviews 2012
Red clover extract exerts antidiabetic and hypolipidemic effects in db/db mice
L Qiu, T Chen, F Zhong, Y Hong, L Chen, H Ye
Experimental and therapeutic medicine 2012
Activation of the farnesoid X receptor induces hepatic expression and secretion of fibroblast growth factor 21
HA Cyphert, X Ge, AB Kohan, LM Salati, Y Zhang, FB Hillgartner
The Journal of biological chemistry 2012
Dehydroepiandrosterone replacement therapy in older adults improves indices of arterial stiffness
EP Weiss, DT Villareal, AA Ehsani, L Fontana, JO Holloszy
Aging Cell 2012
Activation of intestinal peroxisome proliferator-activated receptor-α increases high-density lipoprotein production
S Colin, O Briand, V Touche, K Wouters, M Baron, F Pattou, R Hanf, A Tailleux, G Chinetti, B Staels, S Lestavel
European Heart Journal 2012
MicroRNA 21 promotes fibrosis of the kidney by silencing metabolic pathways
BN Chau, C Xin, J Hartner, S Ren, AP Castano, G Linn, J Li, PT Tran, V Kaimal, X Huang, AN Chang, S Li, A Kalra, M Grafals, D Portilla, DA MacKenna, SH Orkin, JS Duffield
Science Translational Medicine 2012
Molecular mechanisms underlying the fetal programming of adult disease
T Vo, DB Hardy
Journal of Cell Communication and Signaling 2012
Potent PPARα Activator Derived from Tomato Juice, 13-oxo-9,11-Octadecadienoic Acid, Decreases Plasma and Hepatic Triglyceride in Obese Diabetic Mice
Y Kim, S Hirai, T Goto, C Ohyane, H Takahashi, T Tsugane, C Konishi, T Fujii, S Inai, Y Iijima, K Aoki, D Shibata, N Takahashi, T Kawada
PloS one 2012
Cell-derived microparticles in atherosclerosis: biomarkers and targets for pharmacological modulation?
M Baron, CM Boulanger, B Staels, A Tailleux, M Simionescu
Journal of Cellular and Molecular Medicine 2012
Effect of fenofibrate and atorvastatin on VLDL apoE metabolism in men with the metabolic syndrome
EM Ooi, TW Ng, GF Watts, DC Chan, PH Barrett
Journal of lipid research 2012
Circadian Rhythms and Obesity in Mammals
O Froy
ISRN Obesity 2012
Peroxisomal localization and circadian regulation of ubiquitin-specific protease 2
MM Molusky, D Ma, K Buelow, L Yin, JD Lin
PloS one 2012
Peroxisome proliferator-activated receptor β/δ induces myogenesis by modulating myostatin activity
S Bonala, S Lokireddy, H Arigela, S Teng, W Wahli, M Sharma, C McFarlane, R Kambadur
The Journal of biological chemistry 2012
In Vitro and In Vivo Characterizations of Chiglitazar, a Newly Identified PPAR Pan-Agonist
He BK, Ning ZQ, Li ZB, Shan S, Pan DS, Ko BC, Li PP, Shen ZF, Dou GF, Zhang BL, Lu XP, Gao Y
PPAR Research 2012
Chronopharmacokinetics of drugs in toxicological aspects: A short review for pharmacy practitioners.
Erkekoglu P, Baydar T
Journal of Research in Pharmacy Practice 2012
Modeling drug- and chemical-induced hepatotoxicity with systems biology approaches.
Bhattacharya S, Shoda LK, Zhang Q, Woods CG, Howell BA, Siler SQ, Woodhead JL, Yang Y, McMullen P, Watkins PB, Andersen ME
Frontiers in physiology 2012
Time-Qualified Patterns of Variation of PPARγ, DNMT1, and DNMT3B Expression in Pancreatic Cancer Cell Lines.
Pazienza V, Tavano F, Francavilla M, Fontana A, Pellegrini F, Benegiamo G, Corbo V, di Mola FF, Di Sebastiano P, Andriulli A, Mazzoccoli G
PPAR Research 2012
Correlations among PPARγ, DNMT1, and DNMT3B Expression Levels and Pancreatic Cancer.
Pazienza V, Tavano F, Benegiamo G, Vinciguerra M, Burbaci FP, Copetti M, di Mola FF, Andriulli A, di Sebastiano P
PPAR Research 2012
Circadian Rhythms, Sleep, and Metabolism
Wenyu Huang, Kathryn Ramsey, Biliana Marcheva, Joseph Bass
Journal of Clinical Investigation 2011
ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-α and PGC-1
G Haemmerle, T Moustafa, G Woelkart, S Büttner, A Schmidt, T de Weijer, M Hesselink, D Jaeger, PC Kienesberger, K Zierler, R Schreiber, T Eichmann, D Kolb, P Kotzbeck, M Schweiger, M Kumari, S Eder, G Schoiswohl, N Wongsiriroj, NM Pollak, FP Radner, K Preiss-Landl, T Kolbe, T Rülicke, B Pieske, M Trauner, A Lass, R Zimmermann, G Hoefler, S Cinti, EE Kershaw, P Schrauwen, F Madeo, B Mayer, R Zechner
Nature Medicine 2011
Peroxisome Proliferator–Activated Receptor-α Gene Level Differently Affects Lipid Metabolism and Inflammation in Apolipoprotein E2 Knock-In Mice
F Lalloyer, K Wouters, M Baron, S Caron, E Vallez, J Vanhoutte, E Baugé, R Shiri-Sverdlov, M Hofker, B Staels, A Tailleux
Arteriosclerosis, thrombosis, and vascular biology 2011
5-Aminoimidazole-4-carboxyamide-ribonucleoside (AICAR)-stimulated hepatic expression of Cyp4a10, Cyp4a14, Cyp4a31, and other peroxisome proliferator-activated receptor α-responsive mouse genes is AICAR 5'-monophosphate-dependent and AMP-activated protein kinase-independent
NN Bumpus, EF Johnson
The Journal of pharmacology and experimental therapeutics 2011
Effect of Synthetic Ligands of PPAR α, β/δ, γ, RAR, RXR and LXR on the Fatty Acid Composition of Phospholipids in Mice
K Weiss, J Mihály, G Liebisch, T Marosvölgyi, G Schmitz, T Decsi, R Rühl
Lipids 2011
Generation and characterization of a humanized PPARδ mouse model
B Gross, N Hennuyer, E Bouchaert, C Rommens, D Grillot, H Mezdour, B Staels
British Journal of Pharmacology 2011
Activation of peroxisome proliferator-activated receptor-alpha stimulates both differentiation and fatty acid oxidation in adipocytes
T Goto, JY Lee, A Teraminami, YI Kim, S Hirai, T Uemura, H Inoue, N Takahashi, T Kawada
Journal of lipid research 2011
Consequences of PPARα Invalidation on Glutathione Synthesis: Interactions with Dietary Fatty Acids
N Guelzim, JF Huneau, V Mathé, A Quignard-Boulangé, PG Martin, D Tomé, D Hermier
PPAR Research 2011
Peroxisome proliferator-activated receptors and hepatitis C virus
M Eslam, MA Khattab, SA Harrison
Therapeutic advances in gastroenterology 2011
PPARδ regulates satellite cell proliferation and skeletal muscle regeneration
AR Angione, C Jiang, D Pan, YX Wang, S Kuang
Skeletal Muscle 2011
Long-term fenofibrate treatment impaired glucose-stimulated insulin secretion and up-regulated pancreatic NF-kappa B and iNOS expression in monosodium glutamate-induced obese rats: Is that a latent disadvantage?
S Liu, Q Liu, L Li, Y Huan, S Sun, Z Shen
Journal of Translational Medicine 2011
The peroxisome proliferator-activated receptor: A family of nuclear receptors role in various diseases.
Tyagi S, Gupta P, Saini AS, Kaushal C, Sharma S
Journal of Advanced Pharmaceutical Technology & Research 2011
A Comparative Study of Mouse Hepatic and Intestinal Gene Expression Profiles under PPARα Knockout by Gene Set Enrichment Analysis.
He K, Wang Q, Yang Y, Wang M, Pan Y
PPAR Research 2011
In vivo correction of COX deficiency by activation of the AMPK/PGC-1α axis.
Viscomi C, Bottani E, Civiletto G, Cerutti R, Moggio M, Fagiolari G, Schon EA, Lamperti C, Zeviani M
Cell Metabolism 2011
Association of osteoarthritis with serum levels of the environmental contaminants perfluorooctanoate and perfluorooctane sulfonate in a large Appalachian population.
Innes KE, Ducatman AM, Luster MI, Shankar A
American Journal of Epidemiology 2011
Dehydroepiandrosterone (DHEA) replacement decreases insulin resistance and lowers inflammatory cytokines in aging humans.
Weiss EP, Villareal DT, Fontana L, Han DH, Holloszy JO
Aging 2011
PPARs: diverse regulators in energy metabolism and metabolic diseases
YX Wang
Cell Research 2010
Nuclear hormone receptors in diabetic nephropathy
XX Wang, T Jiang, M Levi
Nature Reviews Nephrology 2010
PPARα: energy combustion, hypolipidemia, inflammation and cancer
SR Pyper, N Viswakarma, S Yu, JK Reddy
Nuclear receptor signaling 2010
Dietary saponins of sea cucumber alleviate orotic acid-induced fatty liver in rats via PPARα and SREBP-1c signaling
XQ Hu, YM Wang, JF Wang, Y Xue, ZJ Li, K Nagao, T Yanagita, CH Xue
Lipids in Health and Disease 2010
CLOCK regulates circadian rhythms of hepatic glycogen synthesis through transcriptional activation of Gys2
R Doi, K Oishi, N Ishida
The Journal of biological chemistry 2010
Peroxisome proliferator-activated receptors, metabolic syndrome and cardiovascular disease
S Azhar
Future Cardiology 2010
PPARs in Bone: The Role in Bone Cell Differentiation and Regulation of Energy Metabolism
B Lecka-Czernik
Current Osteoporosis Reports 2010
Regulation of Hepatic ApoC3 Expression by PGC-1β Mediates Hypolipidemic Effect of Nicotinic Acid
C Hernandez, M Molusky, Y Li, S Li, JD Lin
Cell Metabolism 2010
Peroxisome Proliferator-activated Receptor α Is Responsible for the Up-regulation of Hepatic Glucose-6-phosphatase Gene Expression in Fasting and db/db Mice*
SS Im, MY Kim, SK Kwon, TH Kim, JS Bae, H Kim, KS Kim, GT Oh, YH Ahn
The Journal of biological chemistry 2010
Minireview: Won’t Get Fooled Again: The Nonmetabolic Roles of Peroxisome Proliferator-Activated Receptors (PPARs) in the Heart
P Lockyer, JC Schisler, C Patterson, MS Willis
Molecular Endocrinology 2010
PPARalpha: an emerging therapeutic target in diabetic microvascular damage.
Hiukka A, Maranghi M, Matikainen N, Taskinen MR
Nature reviews. Endocrinology 2010
Role of PPARs in Radiation-Induced Brain Injury
S Ramanan, W Zhao, DR Riddle, ME Robbins
PPAR Research 2010
Various Terpenoids Derived from Herbal and Dietary Plants Function as PPAR Modulators and Regulate Carbohydrate and Lipid Metabolism
T Goto, N Takahashi, S Hirai, T Kawada
PPAR Research 2010
Peroxisome Proliferator-Activated Receptors Protect against Apoptosis via 14-3-3
KK Wu
PPAR Research 2010
Gene Expression Profiling in Wild-Type and PPARα-Null Mice Exposed to Perfluorooctane Sulfonate Reveals PPARα-Independent Effects.
Rosen MB, Schmid JR, Corton JC, Zehr RD, Das KP, Abbott BD, Lau C
PPAR Research 2010
NR4A orphan nuclear receptors: transcriptional regulators of gene expression in metabolism and vascular biology.
Zhao Y, Bruemmer D
Arteriosclerosis, thrombosis, and vascular biology 2010
Profiling of promoter occupancy by PPARα in human hepatoma cells via ChIP-chip analysis
van der Meer DL, Degenhardt T, Väisänen S, de Groot PJ, Heinäniemi M, de Vries SC, Müller M, Carlberg C, Kersten S
Nucleic Acids Research 2010
Effect of feeding regimens on circadian rhythms: Implications for aging and longevity
Froy O, Miskin R
Aging 2010
Comparative studies of skeletal muscle proteome and transcriptome profilings between pig breeds.
Kim NK, Park HR, Lee HC, Yoon D, Son ES, Kim YS, Kim SR, Kim OH, Lee CS
Mammalian genome : official journal of the International Mammalian Genome Society 2010
PPARα agonist prevented the apoptosis induced by glucose and fatty acid in neonatal cardiomyocytes.
Nan WQ, Shan TQ, Qian X, Ping W, Bing GA, Ying LL
Journal of Endocrinological Investigation 2010
Management of dyslipidemia in people with type 2 diabetes mellitus.
Dunn FL
Reviews in endocrine & metabolic disorders 2010
Peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) but not PPARalpha serves as a plasma free fatty acid sensor in liver
LM Sanderson, T Degenhardt, A Koppen, E Kalkhoven, B Desvergne, M Müller, S Kersten
Molecular and cellular biology 2009
Rexinoid Bexarotene Modulates Triglyceride but not Cholesterol Metabolism via Gene-Specific Permissivity of the RXR/LXR Heterodimer in the Liver
F Lalloyer, TA Pedersen, B Gross, S Lestavel, S Yous, E Vallez, JA Gustafsson, S Mandrup, C Fiévet, B Staels, A Tailleux
Arteriosclerosis, thrombosis, and vascular biology 2009
Blunted Akt/FOXO signalling and activation of genes controlling atrophy and fuel use in statin myopathy: Blunted Akt/FOXO signalling in statin-induced myopathy
JE Mallinson, D Constantin-Teodosiu, J Sidaway, FR Westwood, PL Greenhaff
The Journal of Physiology 2009
Glucocorticoids and thiazolidinediones interfere with adipocyte-mediated macrophage chemotaxis and recruitment
D Patsouris, JG Neels, WQ Fan, PP Li, MT Nguyen, JM Olefsky
The Journal of biological chemistry 2009
NR4A Orphan Nuclear Receptors in Cardiovascular Biology
Y Zhao, D Bruemmer
Drug discovery today. Disease mechanisms 2009
Skeletal muscle growth and fiber composition in mice are regulated through the transcription factors STAT5a/b: linking growth hormone to the androgen receptor
P Klover, W Chen, BM Zhu, L Hennighausen
The FASEB Journal 2009
Increased Proximal tubule PPARα in KAP2-PPARα Tg mice confers protection during acute kidney injury
S Li, KK Nagothu, V Desai, T Lee, W Branham, C Moland, JK Megyesi, MD Crew, D Portilla
Kidney International 2009
CD36 gene deletion decreases oleoylethanolamide levels in small intestine of free-feeding mice
A Guijarro, J Fu, G Astarita, D Piomelli
Pharmacological research : the official journal of the Italian Pharmacological Society 2009
FAAH deficiency promotes energy storage and enhances the motivation for food
C Touriño, F Oveisi, J Lockney, D Piomelli, R Maldonado
International Journal of Obesity 2009
The combined impact of metabolic gene polymorphisms on elite endurance athlete status and related phenotypes
II Ahmetov, AG Williams, DV Popov, EV Lyubaeva, AM Hakimullina, ON Fedotovskaya, IA Mozhayskaya, OL Vinogradova, IV Astratenkova, HE Montgomery, VA Rogozkin
Human Genetics 2009
Hypoxia-Inducible Factor 2 Regulates Hepatic Lipid Metabolism
EB Rankin, J Rha, MA Selak, TL Unger, B Keith, Q Liu, VH Haase
Molecular and cellular biology 2009
miRNA in the regulation of skeletal muscle adaptation to acute endurance exercise in C57Bl/6J male mice
A Safdar, A Abadi, M Akhtar, BP Hettinga, MA Tarnopolsky
PloS one 2009
SUMOylation of human peroxisome proliferator-activated receptor alpha inhibits its trans-activity through the recruitment of the nuclear corepressor NCoR
B Pourcet, I Pineda-Torra, B Derudas, B Staels, C Glineur
The Journal of biological chemistry 2009
Fenofibrate inhibits adipocyte hypertrophy and insulin resistance by activating adipose PPARα in high fat diet-induced obese mice
S Jeong, M Yoon
Experimental and Molecular Medicine 2009
Mitochondrial 2,4-dienoyl-CoA reductase deficiency in mice results in severe hypoglycemia with stress intolerance and unimpaired ketogenesis
IJ Miinalainen, W Schmitz, A Huotari, KJ Autio, R Soininen, EV van Themaat, M Baes, KH Herzig, E Conzelmann, JK Hiltunen
PLoS genetics 2009
Nuclear Receptor-Coregulator Interaction Profiling Identifies TRIP3 as a Novel Peroxisome Proliferator-activated Receptor γ Cofactor
Koppen A, Houtman R, Pijnenburg D, Jeninga EH, Ruijtenbeek R, Kalkhoven E
Molecular & cellular proteomics : MCP 2009
Effect of fenofibrate on microcirculation and wound healing in healthy and diabetic mice
Valentin S, Rudolph J, Goertz O, Botteck N, Langer S, Schneider S
European Journal of Medical Research 2009
Fat-induced satiety factor oleoylethanolamide enhances memory consolidation
Campolongo P, Roozendaal B, Trezza V, Cuomo V, Astarita G, Fu J, McGaugh JL, Piomelli D
Proceedings of the National Academy of Sciences 2009
Drug therapy for hypertriglyceridemia: fibrates and omega-3 fatty acids.
Toth PP, Dayspring TD, Pokrywka GS
Current Atherosclerosis Reports 2009
PPARalpha agonist fenofibrate suppresses tumor growth through direct and indirect angiogenesis inhibition
D Panigrahy, A Kaipainen, S Huang, CE Butterfield, CM Barnés, M Fannon, AM Laforme, DM Chaponis, J Folkman, MW Kieran
Proceedings of the National Academy of Sciences 2008
Hexarelin Signaling to PPARγ in Metabolic Diseases
A Demers, A Rodrigue-Way, A Tremblay
PPAR Research 2008
The lipid messenger OEA links dietary fat intake to satiety
GJ Schwartz, J Fu, G Astarita, X Li, S Gaetani, P Campolongo, V Cuomo, D Piomelli
Cell Metabolism 2008
Hemodynamic Effects of Fenofibrate and Coenzyme Q10 in Type 2 Diabetic Subjects With Left Ventricular Diastolic Dysfunction
GT Chew, GF Watts, TM Davis, BG Stuckey, LJ Beilin, PL Thompson, V Burke, PJ Currie
Diabetes care 2008
Multiple Interactions between Peroxisome Proliferators-Activated Receptors and the Ubiquitin-Proteasome System and Implications for Cancer Pathogenesis
D Genini, GM Carbone, CV Catapano
PPAR Research 2008
Albumin-Associated Lipids Regulate Human Embryonic Stem Cell Self-Renewal
FR Garcia-Gonzalo, JC Belmonte, S Rutherford
PloS one 2008
New approaches to target microsomal triglyceride transfer protein
MM Hussain, A Bakillah
Current Opinion in Lipidology 2008
PPARs and Female Reproduction: Evidence from Genetically Manipulated Mice
J Yang, L Chen, X Zhang, Y Zhou, D Zhang, M Huo, Y Guan
PPAR Research 2008
The glucagon receptor is required for the adaptive metabolic response to fasting
C Longuet, EM Sinclair, A Maida, LL Baggio, M Maziarz, MJ Charron, DJ Drucker
Cell Metabolism 2008
The PPARα/p16 INK4a Pathway Inhibits Vascular Smooth Muscle Cell Proliferation by Repressing Cell Cycle–Dependent Telomerase Activation
F Gizard, T Nomiyama, Y Zhao, HM Findeisen, EB Heywood, KL Jones, B Staels, D Bruemmer
Circulation research 2008
Synergistic Effects of PPARgamma Ligands and Retinoids in Cancer Treatment
M Shimizu, H Moriwaki
PPAR Research 2008
Farnesol Decreases Serum Triglycerides in Rats: Identification of Mechanisms Including Up-Regulation of PPARα and Down-Regulation of Fatty Acid Synthase in Hepatocytes
RE Duncan, MC Archer
Lipids 2008
A Natural Polymorphism in Peroxisome Proliferator-Activated Receptor-α Hinge Region Attenuates Transcription due to Defective Release of Nuclear Receptor Corepressor from Chromatin
MH Liu, J Li, P Shen, B Husna, ES Tai, EL Yong
Molecular Endocrinology 2008
Should We Use PPAR Agonists to Reduce Cardiovascular Risk?
Robinson JG
PPAR Research 2008
Nuclear receptor signalling in dendritic cells connects lipids, the genome and immune function
Szatmari I, Nagy L
The EMBO Journal 2008
Current and novel therapies for the treatment of nonalcoholic steatohepatitis
D der Poorten, J George
Hepatology International 2007
PPARs, Obesity, and Inflammation
R Stienstra, C Duval, M Müller, S Kersten
PPAR Research 2007
Role and regulation of acylethanolamides in energy balance: focus on adipocytes and beta-cells
I Matias, MP Gonthier, S Petrosino, L Docimo, R Capasso, L Hoareau, P Monteleone, R Roche, AA Izzo, VD Marzo
British Journal of Pharmacology 2007
Nuclear receptors: decoding metabolic disease
J Sonoda, L Pei, RM Evans
FEBS Letters 2007
Genetic links between diabetes mellitus and coronary atherosclerosis
JM Ordovas
Current Atherosclerosis Reports 2007
IP receptor-dependent activation of PPARgamma by stable prostacyclin analogues
E Falcetti, DM Flavell, B Staels, A Tinker, SG Haworth, LH Clapp
Biochemical and Biophysical Research Communications 2007
Energizing miRNA research: a review of the role of miRNAs in lipid metabolism, with a prediction that miR-103/107 regulates human metabolic pathways
Wilfred BR, Wang WX, Nelson PT
Molecular Genetics and Metabolism 2007
Variation in the peroxisome proliferator-activated receptor delta gene in relation to common metabolic traits in 7,495 middle-aged white people.
Grarup N, Albrechtsen A, Ek J, Borch-Johnsen K, Jørgensen T, Schmitz O, Hansen T, Pedersen O
Diabetologia 2007
Update on PPAR agonists: the clinical significance of FIELD and PROACTIVE.
Robinson JG
Current Atherosclerosis Reports 2007
The human myeloperoxidase gene is regulated by LXR and PPARalpha ligands
WF Reynolds, AP Kumar, FJ Piedrafita
Biochemical and Biophysical Research Communications 2006
Going nuclear in metabolic and cardiovascular disease
CK Glass
Journal of Clinical Investigation 2006
Familial Dyslipidaemias: An Overview of Genetics, Pathophysiology and Management
SB Hachem, AD Mooradian
Drugs 2006
Fibrate therapy in patients with metabolic syndrome and diabetes mellitus.
Dayspring T, Pokrywka G
Current Atherosclerosis Reports 2006

← Previous 1 2 3 4 … 15 16 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 5 patents
Referenced in 3 Wikipedia pages
379 readers on Mendeley
1 readers on CiteULike
See more details